연구동향 분석

The Immunogenicity of a Single Dose of Hepatitis A Virus Vaccines (Havrix® and Epaxal®) in Korean Young Adults

임지선 기모란 송영준 박웅섭 손혜숙 이무식 신동훈 김춘배 김화성 오경재 2014년

논문상세정보
인용/피인용
' The Immunogenicity of a Single Dose of Hepatitis A Virus Vaccines (Havrix® and Epaxal®) in Korean Young Adults' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • hepatitis a virus
  • hepatitisavaccine
  • immune
  • vaccine
  • young adults
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,840 0

0.0%

' The Immunogenicity of a Single Dose of Hepatitis A Virus Vaccines (Havrix® and Epaxal®) in Korean Young Adults' 의 참고문헌

  • 우리나라 남녀 성인의 폭음 및 문제음주 영향 요인
    전경숙 보건교육건강증진학회지 27 (1) : 91 ~ 103 [2010]
  • 우리나라 남녀 성인의 폭음 및 문제음주 영향 요인
    전경숙 보건교육건강증진학회지 27 1 91-103 [2010]
  • WHO position paper on hepatitis A vaccines-June 2012
    Wkly Epidemiol Rec 87 : 261 ~ 276 [2012]
  • WHO position paper on hepatitis A vaccines-June 2012
    Wkly Epidemiol Rec 87 261-276 [2012]
  • Tolerance and immunogenicity of the simultaneous administration of virosome hepatitis A and yellow fever vaccines
    Bovier PA J Travel Med 6 : 228 ~ 233 [1999]
  • Tolerance and immunogenicity of the simultaneous administration of virosome hepatitis A and yellow fever vaccines
    Bovier PA J Travel Med 6 228-233 [1999]
  • The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults
    Reuman PD Vaccine 15 : 1157 ~ 1161 [1997]
  • The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults
    Reuman PD Vaccine 15 1157-1161 [1997]
  • The Asia-Pacific perspective: Redefining obesity and its treatment IOTF, Health Communications Australia Pty Ltd
    Force IOT World Health Organization/International Association for the Study of Obesity [2000]
  • The Asia-Pacific perspective: Redefining obesity and its treatment IOTF, Health Communications Australia Pty Ltd
    Force IOT - [2000]
  • Rapid antibody response after vaccination with a virosomal hepatitis a vaccine
    Ambrosch F Infection 32 : 149 ~ 152 [2004]
  • Rapid antibody response after vaccination with a virosomal hepatitis a vaccine
    Ambrosch F Infection 32 149-152 [2004]
  • Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults
    Hammitt LL J Infect Dis 198 : 1776 ~ 1782 [2008]
  • Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults
    Hammitt LL J Infect Dis 198 1776-1782 [2008]
  • Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine
    Maiwald H Vaccine 15 : 346 ~ 348 [1997]
  • Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine
    Maiwald H Vaccine 15 346-348 [1997]
  • Long-term immunity after two doses of inactivated hepatitis A vaccine, in Argentinean children
    López EL Pediatr Infect Dis J 29 : 568 ~ 570 [2010]
  • Long-term immunity after two doses of inactivated hepatitis A vaccine, in Argentinean children
    López EL Pediatr Infect Dis J 29 568-570 [2010]
  • Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine
    Bovier PA Vaccine 23 : 2424 ~ 2429 [2005]
  • Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine
    Bovier PA Vaccine 23 2424-2429 [2005]
  • Inactivated hepatitis A vaccine booster given >/=24 months after the primary dose
    Landry P Vaccine 19 : 399 ~ 402 [2000]
  • Inactivated hepatitis A vaccine booster given >/=24 months after the primary dose
    Landry P Vaccine 19 399-402 [2000]
  • Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly
    D’Acremont V J Travel Med 13 : 78 ~ 83 [2006]
  • Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly
    D’Acremont V J Travel Med 13 78-83 [2006]
  • Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial
    Holzer BR Vaccine 14 : 982 ~ 986 [1996]
  • Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial
    Holzer BR Vaccine 14 982-986 [1996]
  • Hepatitis B vaccines
    Yu AS Clin Liver Dis 8 : 283 ~ 300 [2004]
  • Hepatitis B vaccines
    Yu AS Clin Liver Dis 8 283-300 [2004]
  • Hepatitis A in Korea: Epidemiological shift and call for vaccine strategy
    Lee D INTERVIROLOGY 51 : 70 ~ 74 [2008]
  • Hepatitis A in Korea: Epidemiological shift and call for vaccine strategy
    Lee D INTERVIROLOGY 51 70-74 [2008]
  • Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years
    Van Herck K J Med Virol 83 : 1885 ~ 1891 [2011]
  • Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years
    Van Herck K J Med Virol 83 1885-1891 [2011]
  • AUDIT: The Alcohol Use Disorders Identification Test. Guidelines for Use in Primary Care. 2nd ed
    Babor TF World Health Organization [2001]
  • AUDIT: The Alcohol Use Disorders Identification Test. Guidelines for Use in Primary Care. 2nd ed
    Babor TF - [2001]